[Avoidable and not avoidable damage in hormone therapy. Cortisone osteoporosis and virilizing effect of anabolic steroids].
D000312:Adrenal Hyperplasia, Congenital; D000328:Adult; D045930:Anabolic Agents / Q000009:adverse effects*; D002127:Calcium Isotopes; D003348:Cortisone / Q000627:therapeutic use; D005260:Female; D005943:Gluconeogenesis; D006801:Humans; D006854:Hydrocortisone / Q000009:adverse effects; D008297:Male; D010024:Osteoporosis / Q000139:chemically induced; D011241:Prednisone / Q000009:adverse effects; D011506:Proteins / Q000378:metabolism; D014044:Tolbutamide / Q000009:adverse effects; D014770:Virilism / Q000139:chemically induced*
D045930:Anabolic Agents; D002127:Calcium Isotopes; D011506:Proteins; D014044:Tolbutamide; D003348:Cortisone; D011241:Prednisone; D006854:Hydrocortisone
Vermeidbare und nicht vermeidbare Schäden der Hormontherapie. Cortisonosteoporose und virilisierende Wirkung der anabolen Steroide.